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Summary
This paper evaluates in vivo predictability of a battery of in vitro tests covering developmental toxicity and 
embryotoxicity of five widely used conazole fungicides. The conazoles were investigated in the embryonic 
stem cell test, and data were compared to in vivo embryotoxicity data. The same conazoles were evaluated 
on the basis of data from a battery of cell assays for endocrine activity, including assays for AR, ER, AhR, 
and sex hormone synthesis, and data were compared to in vivo developmental toxicity data. Overall,  
the ranking of the five conazole fungicides based on in vitro data were in reasonably good agreement with 
available in vivo effects. Ketoconazole and epoxiconazole are the most potent embryotoxic compounds, 
whereas prochloraz belongs to the most potent developmental toxicants. In conclusion, a rough prediction 
of the ranking of these conazole fungicides for in vivo toxicity data was possible by a holistic evaluation  
of data from a panel of cell-based assays.
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embryotoxicity. In this paper we have assessed the embryotox-
ic potential in vitro of five conazole fungicides and compared 
these and other in vitro results to our own and other published 
data from in vivo developmental animal studies.
Imidazoles and triazoles currently are used worldwide as fun-
gicides for grain, vegetables, fruit, and flower production and as 
pharmaceuticals for treatment of human mycoses (Kjaerstad et 
al., 2010b). their pharmacological action is based on the bind-
ing and inhibition of the enzyme lanosterol-14-α-demethylase 
(CYP51) that converts lanosterol to ergosterol in fungal cell 
membranes (Giavini and Menegola, 2010). However, CYP in-
hibitory ability of these compounds is not limited to this enzyme 
or to fungi. Some conazole fungicides have been shown to in-
fluence the activity of other members of the CYP450 family, 
including key enzymes involved in the biosynthesis and me-
tabolism of steroids in humans and animals. two examples are 
17α-hydroxylase/17,20-lyase (CYP17) and aromatase enzyme 
(CYP19) that are responsible for the conversion of pregnenolo-
ne and progesterone to androgens and the conversion of andro-
gens to estrogens, respectively (Kjaerstad et al., 2010a; taxvig 
et al., 2007; Vinggaard et al., 2000).
Beside interference with the CYP450 monooxygenases, co-
nazole fungicides have been found to antagonize steroid hor-
mone receptors such as the androgen (AR) and estrogen recep-
tor (eR), along with an ability to activate the aryl hydrocarbon 
receptor (AhR) in cell assays (Vinggaard et al., 2000; Andersen 
1  Introduction
toxicology faces a great challenge as humans are exposed to 
large numbers of chemicals for which we lack toxicological 
information. the lack of toxicity data calls for new approach-
es. Some see the future in the strength of in vitro and in silico 
methodologies based on human material in which pathways of 
toxicity can be elucidated and evaluated by a holistic approach. 
Apart from convincing scientific visions and arguments, a vari-
ety of other good reasons exist for promoting the development 
of cell-based alternatives to animal testing. these include im-
portant political, ethical, as well as economic reasons. In 2013 
the final ban on using animals to test ingredients for cosmet-
ics in the eU came into force although alternative methods are 
still lacking for various endpoints. ReACH – the eU legisla-
tion on chemicals – requires comprehensive testing of many 
“old” substances. Performing this testing in animals would be 
time-consuming and costly and therefore alternative methods 
are needed. Pharmaceutical companies have a great interest to 
develop early, predictive toxicity tests for termination of prob-
lematic drug candidates early on.
Good case studies are needed to assess the predictability and 
value of in vitro tests. We have studied conazole fungicides in 
vitro and in vivo for a number of years and have compiled the 
data for the purpose of retrospectively evaluating the predictive 
potential of in vitro tests in terms of developmental toxicity and 
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et al., 2002; Kjaerstad et al., 2007). Additionally, epoxicona-
zole and propiconazole gave rise to a weak estrogenic response 
in the MCF-7 cell proliferation assay (Kjaerstad et al., 2007). 
Taken together, this indicates that the conazoles might have 
multiple modes of action in regard to affecting reproductive 
development. evidence for their adverse effects on develop-
ment has been presented by rodent studies. Prochloraz, e.g., 
caused feminization and sexual malformations in male off-
spring after gestational and lactational exposure (Blystone et 
al., 2007; Vinggaard et al., 2005). Despite these known adverse 
effects, prochloraz was re-approved by the EU Commission in 
late 2011 after a short withdrawal, and it currently is approved 
for a wide variety of crops in the european Union (Muilerman 
et al., 2012).
Beside their effect on reproductive development, conazoles, 
including ketoconazole, epoxiconazole, and tebuconazole, have 
shown another toxicological potential in animal studies as they 
cause, e.g., increased embryolethality, cleft palate, reduced fetal 
weight, and axial skeleton malformations (Giavini and Mene-
gola, 2010; Marotta and tiboni, 2010). Human epidemiological 
studies on various azole antifungals found no associations be-
tween exposure to either triazole or imidazole substances during 
pregnancy (Marotta and tiboni, 2010). However, Marotta and 
Tiboni (2010) state that these findings cannot be regarded as 
conclusive, given the methodological problems and limitations 
of the majority of the available human studies. Consequently, 
several triazoles and imidazoles, e.g., ketoconazole used for 
treatment of fungal infections were classified by the U.S. Food 
and Drug Administration, according to the risk in pregnancy, 
as category C (teratogenic or embryotoxic in animal studies 
without available reports or studies on humans). For this reason, 
the conazoles, used as drugs for systemic therapy against deep-
seated infections, extensive cutaneous diseases, and/or hair or 
nail mycosis are not recommended during the first trimester or 
during the pregnancy period in general, depending on the type 
of conazole fungicide (Menegola et al., 2006).
the cause of the teratogenic effect has been suggested to be 
another important group of enzymes believed to be inhibited by 
the conazoles, i.e., the CYP26 family. This family plays a crucial 
role in controlling endogenous retinoic acid (RA) levels in em-
bryonic tissue. Imbalance in RA metabolism caused by triazoles 
has been demonstrated both in vitro and in vivo (Marotta and 
tiboni, 2010). An increased level of endogenous RA was the 
suggested mechanism behind altered craniofacial morphogen-
esis such as cleft palate and reduced ossification of skull bones 
after in utero exposure to ketoconazole (Amaral and Nunes, 
2008). Another possible mechanism for the developmental tox-
icity of conazole compounds might be via blocking of cardiac 
potassium channels. Chemicals blocking these channels cause 
malformations by a common embryonic cardiac arrhythmia/hy-
poxia mechanism (Danielsson et al., 2007). Recently, ketocona-
zole and other conazole compounds have been found to strongly 
inhibit cardiac potassium channels in neonatal rat ventricular 
myocytes (Sung et al., 2012) suggesting an alternative mode of 
action for the teratogenic effects of conazoles.
Overall, literature provides relatively comprehensive infor-
mation on the in vivo effects of conazole fungicides in rodents. 
In addition, there is fairly extensive in vitro information on the 
potential endocrine activity of these compounds. However, 
knowledge of embryotoxicity in vitro was lacking in order to 
perform a holistic evaluation of the predictability of in vitro 
assays for embryotoxicity as well as for developmental toxic-
ity. Hence, in this paper we first investigated the embryotoxic 
potential of five conazole fungicides, i.e., epoxiconazole, keto-
conazole, prochloraz, propiconazole, and tebuconazole in vitro 
using the embryonic stem cell test (eSt). this assay currently 
is a promising approach to assess the embryotoxic potency of 
chemicals in vitro (Adler et al., 2008). It was developed to re-
duce animal use and represents an alternative test method for 
hazard assessment (Riebeling et al., 2011). A scientific valida-
tion by the european Center for the Validation of Alternative 
Methods (eCVAM) demonstrated that this test may be a relia-
ble alternative or supplementary method to animal experiments 
testing for embryotoxicity. However, there is a need for further 
testing and evaluation of more chemicals by this method before 
it can be considered for regulatory acceptance and application 
(Genschow et al., 2002, 2004; Kuske et al., 2012; Marx-Stoelt-
ing et al., 2009). We gathered the available in vitro and in vivo 
information from literature with the aim of elucidating, retro-
spectively, whether we could have predicted developmental in 
vivo outcomes in animals from the selected battery of in vitro 
tests. Such information is important to learn from, as a future 
target is to design a panel of in vitro tests that can be used for 
predicting human toxic effects.
2  Materials and methods
Principle of EST
the principle and establishment of the eSt has been described 
previously (Seiler et al., 2006). Briefly, two stable mouse cell 
lines were used: 1) an embryonic stem (eS) cell clone D3 to rep-
resent undifferentiated embryonic tissue and 2) 3T3 fibroblasts 
to represent differentiated adult tissue. Suspension cultures of 
stem cells that spontaneously differentiate and form multicel-
lular aggregates are referred to as embryonic bodies (eBs). Plat-
ing of the eBs allowed further differentiation and outgrowth, 
and the morphological assessment of contracting cardiomyo-
cytes was used as an endpoint for differentiation (Seiler et al., 
2006; Seiler and Spielmann, 2011). In order to predict the in 
vivo embryotoxic potential of a test compound a biostatistical 
model was applied (Seiler et al., 2006).
Chemicals
the following test compounds – all from Dr ehrendorfer – 
were used: epoxiconazole 99% pure (CAS 106325-08-0, cat. 
EHRC 13185000), ketoconazole 99% pure (CAS 65277-42-1, 
cat. EHRC14532000), prochloraz 99.6% pure (CAS 67747-09-
5, cat. W16290000), propiconazole 97.5% pure (CAS 60207-
90-1, cat. EHRC16480000), and tebuconazole 98% pure (CAS 
107534-96-3, cat. EHRC17178700). All test compounds were 
dissolved in dimethylsulfoxide (DMSO, Sigma, cat. D4540). 
Positive control was 5-fluorouracil (5-FU, CAS 51-21-8, Sig-
ma, cat. F-6627) in DMSO. Negative control was penicillin G 
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day ten with changes of medium containing test compound on 
days three and five. On day ten, a resazurin (Sigma, cat. 1770) 
solution in PBS was added directly to the wells for a final con-
centration of 2.5 µg resazurin/ml and incubated for three hours. 
Fluorescent signal was monitored using 560 nm excitation and 
590 nm emission wavelength. Cytotoxicity of ketoconazole 
was tested in the concentration range 1.6-100 µM (n=3) and for 
propiconazole, epoxiconazole, prochloraz, and tebuconazole in 
the concentration range 7.8-500 µM (n=4).
Statistics
Three single endpoint values (50% inhibition of cardiac cell 
differentiation (ID50), 50% viability of D3 cells (IC50D3), 
and 50% viability of 3T3 cells (IC503t3)) for differentiation 
and cytotoxicity were determined from dose-response-curves 
(x = log(x)) using non-linear “Sigmoidal dose-response (vari-
able slope)” fitted in GraphPad Prism 5. Constraints for bottom 
were between 0 and 100, and top was constant equal to 100. A 
biostatistically-based prediction model (PM) that takes the three 
variables into account was applied to discriminate between 
three classes of embryotoxicity (non-embryotoxic, weakly em-
bryotoxic, and strongly embryotoxic) as shown below. the PM 
for the eSt has been described previously (Genschow et al., 
2002, 2004).
Classification criteria
Class I: Non-embryotoxic if I>II and I>III
Class II: Weakly embryotoxic if II>I and II>III
Class III: Strongly embryotoxic if III>I and III>II
3  Results and discussion
Five conazole fungicides, three triazoles and two imidazoles, 
were tested for embryotoxic effects in the in vitro eSt assay. 
the purpose was to evaluate how well the eSt assay predicts 
the embryotoxic potential of conazole fungicides. The results, 
therefore, were compared to embryotoxicity in animals. Fur-
thermore, we wanted to compare previously published in vitro 
data for endocrine activity with developmental toxicity out-
comes from animal studies for the same fungicides.
eSt endpoint values (ID50, IC50D3, and IC503t3) and their 
95% confidence intervals (95% C.I.) were derived from the 
non-linear regression lines in Figure 1 and shown in table 1. 
IC50 values for resazurin reduction were in the range of ap-
proximately 10-76 µM and 25-132 µM for D3 and 3T3 cells, 
respectively, and 50% inhibition of cardiac beating was found 
in the range of approximately 15-69 µM (Tab. 1). All five cona-
zoles were classified as “weakly embryotoxic” when using the 
prediction model developed for the eSt assay (Genschow et al., 
2002, 2004).
the original eSt has been expanded using, e.g., transcriptom-
ics in eS cells or metabolomics of pluripotent human eS cells 
(PenG, CAS 69-57-8, Sigma, cat. A2058) in water. Cell medium 
solutions were constantly shaken during addition to plates in 
order to avoid precipitation.
Cell culture
Undifferentiated murine eS cells clone D3 (AtCC, cat. CRl-
1934) were cultured in humidified atmosphere at 37°C and 
5% CO2 in high-glucose Dulbecco’s Modified Eagle’s Medium 
(DMEM, Gibco, cat. 41965-039) containing 20% heat-inacti-
vated fetal calf serum (FCS, Hyclone, cat. A-1111-l), antibiot-
ics (50 U/ml penicillin and 50 µg/ml streptomycin, Invitrogen, 
cat. 15070-063), 1% non-essential amino acids (NEAA, Gibco, 
cat. 11140-035), 2 mM L-glutamine (Gibco, cat. 25030-024), 
0.1 mM β-mercaptoethanol (Sigma, cat. M7522). The cells 
were maintained in the presence of murine leukemia inhibitory 
factor (lIF, Sigma, cat. l5158-5UG) to inhibit spontaneous dif-
ferentiation.
Balb/c 3T3 fibroblasts of type A31 (ATCC, cat. CCL-163) 
were cultured under similar conditions in high-glucose DMeM 
with 50 U/ml penicillin, 50 µg/ml streptomycin, 10% heat-inac-
tivated FCS, and 4 mM L-glutamine.
EST differentiation assay
The scientifically validated EST assay has been described in 
detail (Seiler et al., 2006). Briefly, suspensions of D3 cells in 
supplemented DMeM without lIF (3.75 x 104 cells/ml) were 
prepared for each concentration of the test chemical. 20 µl cell 
suspension was placed as hanging drops on the lid of a bacte-
rial Petri dish filled with 5 ml phosphate buffered saline (PBS, 
OXOID, cat. BR0014g) and incubated for three days. During 
this period the cells aggregate to form eBs. After three days 
the eBs were transferred to a Petri dish with 10 ml medium 
containing test concentration of each chemical and further culti-
vated as suspension culture for two days. On day five, separate 
EBs were plated into a 24-multiwell culture plate (Sarstedt, cat. 
83.1835.300) containing 1 ml medium/well with test compound. 
Differentiation was evaluated by microscopic inspection on day 
ten by determining the number of contracting cardiomyocytes 
in each well on each plate and comparing the number to the 
number of contracting eBs in the solvent control plate. experi-
ments were considered valid when 21 of 24 wells in the solvent 
control plate contained spontaneously beating cardiomyocytes. 
Interference with differentiation was evaluated at six test con-
centrations for each test compound between 4-128 µM in three 
independent experiments, except for tebuconazole, which was 
tested four times.
Cytotoxicity assay
Roughly, the cytotoxicity data is used to assess if stem cells are 
more sensitive to toxic agents than adult cells by determining the 
inhibition of growth of D3 and 3t3 cells. In the current study, 
cytotoxic effects on D3 and 3t3 were determined by applying 
the resazurin assay. 500 D3 cells/well and 2,000 3T3 cells/well 
were allowed to attach during incubation for two hours in a 
black clear-bottomed 96-well plate (Biotech Line, cat. 3603) be-
fore adding medium with test compounds, the positive control, 
5-FU, or the negative control, PenG. Cells were incubated until 
Function I:         (       )           (      )      (                   )       
Function II:         (       )           (      )      (                   )       




Tab. 1: Embryonic Stem Cell Test endpoints for five conazole compounds
EST endpoints and their 95% confidence intervals (95% C.I.) were derived from the non-linear regressions to  
the plots in Fig. 1; a = ID50 and/or IC50 values were considered different as their 95% C.I. were not overlapping.
      In vitro EST assay endpoints
Conazole ID50, µM IC50D3, µM IC503T3, µM EST ID50/IC50D3 IC50D3/IC503T3 
fungicide (95% C.I.) (95% C.I.) (95% C.I.) classification ratio ratio
Epoxiconazole 33.8 (25.6-44.5) 69.4 (51.3-94.0) 97.0 (40.1-234.6) Weakly embryotoxic 0.5a 0.7
Ketoconazole 15.4 (14.1-16.9) 9.9 (7.0-14.1) 25.6 (20.3-32.2) Weakly embryotoxic 1.6 0.4a
Prochloraz 36.5 (24.6-54.2) 46.7 (38.7-56.5) 60.1 (42.4-87.2) Weakly embryotoxic 0.8 0.8
Propiconazole 46.3 (31.8-67.3) 76.1 (62.0-93.4) 116.8 (69.7-195.5) Weakly embryotoxic 0.6 0.7
Tebuconazole 69.1 (44.4-107.4) 74.7 (44.0-126.6) 131.9 (87.1-199.9) Weakly embryotoxic 0.9 0.6
Fig. 1: Dose-response curves for inhibition of beating occurrence of embryonic stem cells and resazurin reduction  
in D3 and 3T3 cells for five selected conazole fungicides
Beating occurrence was evaluated in three independent experiments (except for tebuconazole, which was tested four times)  
and the resazurin reduction experiments were conducted four times (except for ketoconazole, which was tested three times).  
Data represent mean ±SEM. The horizontal dashed lines represent 50% of control level.
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Similarly, IC50D3/IC503t3 ratios were estimated to compare 
the D3 cell toxicity versus 3T3 fibroblast cytotoxicity. Ketoco-
nazole exhibited an IC50D3/IC503t3 ratio below 0.5 with non-
overlapping 95% confidence intervals between the IC50D3 and 
IC503t3 values indicating a greater sensitivity of embryonic 
cells towards the cytotoxic effects of this fungicide. Ketocona-
zole inhibited the embryonic differentiation process at signifi-
cantly lower concentrations than the other conazoles, since ke-
toconazole had the lowest ID50 value with non-overlapping 95% 
confidence intervals.
Although all five conazole compounds were classified as 
“weakly embryotoxic” by the PM, a ranking of the potencies 
according to the ID50 values was performed to position the com-
pounds relative to their embryotoxicity, resulting in the follow-
ing order: ketoconazole > epoxiconazole ≈ prochloraz > propi-
conazole ≈ tebuconazole.
Publically available data from in-house experiments or oth-
ers’ studies on selected in vivo embryotoxic effects of the co-
nazoles were gathered and presented in Table 2. The endpoints 
included were direct toxic effects to the fetus such as implanta-
tion loss, fetal/birth weight, number of resorptions, number of 
live fetuses, malformations, postnatal death, and pup weight or 
to identify embryotoxic compounds (van Dartel et al., 2011; 
West et al., 2010). Chandler et al. (2011) modified to deliver a 
high-throughput, sensitive method for quantitatively measuring 
cardiomyocyte differentiation using primary mouse antibody 
that recognizes α and β cardiac myosin heavy chain. Two of 
the present fungicides, i.e., prochloraz and propiconazole, were 
tested along with other related conazole compounds. Half-maxi-
mal activity concentration (AC50) values for cardiomyocyte dif-
ferentiation were determined to be 12 and 9, respectively. these 
values are lower than the ID50 values found in this study and 
indicate that expanding the endpoints in the eSt might heighten 
the sensitivity of this assay.
the ID50/IC50D3 ratio was used as a measure for specific 
inhibition of the differentiation process versus cytotoxicity 
(Stummann et al., 2008). The 95% confidence intervals for the 
ID50 and IC50D3 were not substantially different for prochlo-
raz, ketoconazole, tebuconazole, and propiconazole implying 
no specific interference with cardiac differentiation, i.e., their 
ID50/IC50D3 ratios are not significantly different from 1. In con-
trast, epoxiconazole had non-overlapping 95% C.I. and an ID50/
IC50D3 ratio of 0.5 (Tab. 1) indicating that this conazole fungi-
cide may induce specific inhibition of cardiac differentiation.
Tab. 2: Overview of embryotoxicity in vivo data for five conazole compounds
Ranges of doses in mg/kg bw/day for significant effects on each specific endpoint are shown. Numbers in parentheses are  
the reference identification numbers as listed in Supplementary materials at www.altex-edition.org. Italic numbers  
refer to the tested dose range in mg/kg bw/day in all included studies. NI = parameter not investigated, NS = effect not significant.  
The lowest lowest-observed-adverse-effect-level (LOAEL) value (in mg/kg bw/day) for each chemical and parameter was  
converted into colors using an arbitrary scale selected as shown in the row marked scale. Non-significant effects were assigned  
the highest LOAEL value on the scale.
                In vivo embryotoxicity endpoints
Conazole Gestation Maternal Implantat- Fetal/birth Resorpt- Live Malformat Postnatal Pup 
fungicides length weight gain ion loss weight ions fetuses -ions death weight 
(mg/kg bw/day)
Epoxiconazole ↑15-50 ↓20-180 ↑50-180 ↓↑15,50 ↑45-180 ↓≈23-180 ↑45 ↑≈23,50 ↓♂≈23 
3.75-250 (1-3) (4-6) (2,5,6,7) (2,7) (4-7) (2,3,5) (4) (2,3) (3)
Ketoconazole NI ↓50,100 ↑10-100 ↓80,100 ↑50-100 ↓40-80 ↑80 NI NI 
50-100  (7,8) (7-10) (8,9) (7-10) (7,11) (9,11)
Prochloraz ↑30-250 ↓30-500 ↑250 ↑♀62.5 ↑160 ↑58-81 ↑50-250 ↑58-250 ↓125-250 
5-500 (12-15) (12,13,15-18) (13) ↓♂100 (19) (15) (13,17) (13,15) (13,14) 
    (13,18) 
Propiconazole NI NS NS ↑♂50 NS ↓250 ↑90,400 NI ↓♂≈145-414 
≈ 7.6-414  (7) (7) (7) (7) (20) (21,22)  (20,23)
Tebuconazole ↑100 ↓60,100 ↑50,100 ↓60,100 NS ↓100 ↑30-120 ↑60,100 ↓100 
6-988 (2) (2,24) (2,7) (2,24,25) (2,7) (26) (25-28) (2,24,29) (29)
Scale LOAEL≤10 10<LOAEL≤30 30<LOAEL≤50 50<LOAEL≤70 70<LOAEL≤100 LOAEL>100
Dreisig et al.
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correlation with the relative in vivo toxicities of the test com-
pounds, closely followed by the eSt.
the same group also developed a novel quantitative evalua-
tion method to assess the development of the zebrafish embryo 
based on specific endpoints in time, i.e., the general morphology 
score (GMS) system, and found comparable ranking of the six 
tested triazole compounds with ranking in vivo (Hermsen et al., 
2011). As pinpointed by this group, it is unlikely that one single 
alternative testing method will be able to give a prediction for 
the entire range of possible mechanisms. Beside their embryo-
toxic effects, triazoles and imidazoles share endocrine disrupt-
ing modes of actions with imidazoles being found to be more 
potent than triazoles (Kjaerstad et al., 2010b). Results from 
various in vitro studies on endocrine disrupting effects of the 
conazoles are gathered and presented in Table 3. These include 
receptor reporter gene assays testing for antagonism or increase 
in transactivational activity of the androgen (AR), estrogen 
(eR), and aryl hydrocarbon (AhR) receptors along with studies 
investigating interference with sex hormone synthesis.
The critical mechanism for both imidazoles and triazoles 
seems to be inhibition of sex hormone biosynthesis, as these 
effects occur at lower concentrations compared to effect con-
centrations obtained in the nuclear receptor-based assays (tab. 
3). Ranking of in vitro endocrine activity of the conazole com-
pounds was therefore carried out solely based on data from the 
steroidogenesis assay based on H295R cells. the ranking of the 
five compounds in terms of in vitro potency on interference with 
steroidogenesis (tab. 3) was found to be:
Decreased estradiol production: 
prochloraz > epoxiconazole > ketoconazole ≈ propiconazole ≈ 
tebuconazole
Decreased testosterone production: 
prochloraz > ketoconazole > tebuconazole > epoxiconazole > 
propiconazole
Increased progesterone production: 
prochloraz > epoxiconazole = propiconazole > ketoconazole > 
tebuconazole
Aromatase inhibition: 
prochloraz > ketoconazole ≈ propiconazole ≈ epoxiconazole > 
tebuconazole
The effect of the conazoles on key enzymes involved in the 
biosynthesis and metabolism of steroids is well known, i.e., 
inhibition of CYP19 (Vinggaard et al., 2000; taxvig et al., 2007; 
Kjaerstad et al., 2010b)  and CYP17 (Laier et al., 2006). In vivo, 
the conazole fungicides also affect hormone levels in dams, i.e., 
ketoconazole, tebuconazole, prochloraz, and epoxiconazole re-
duced estradiol levels, and epoxiconazole increased testosterone 
plasma concentration in dams after exposure during pregnancy 
(taxvig et al., 2007, 2008; Blystone et al., 2007). this may be 
the result of aromatase inhibition by these substances. Further-
more, epoxiconazole and tebuconazole increased progesterone 
levels in dams on GD21, i.e., one or two days before expected 
birth (taxvig et al., 2007, 2008). Overall these data are in line 
with the hormonal effects observed in the H295R assay (tab. 
3). the effects on testosterone and progesterone biosynthesis 
maternal effects such as gestational length and maternal weight 
gain. Although maternal weight gain and gestational length may 
be due to other mechanisms, such as maternal toxicity or hor-
monal changes, respectively, they were included as embryotox-
ic parameters, since they both can lead to increased fetal death. 
In this study, ranking the conazole fungicides relative to in vivo 
embryotoxicity was based on the lowest lowest-observed-ad-
verse-effect-levels (lOAels) and the number of affected end-
points among the selected endpoints in the table, resulting in the 
following order: ketoconazole > epoxiconazole > prochloraz > 
propiconazole ≈ tebuconazole. This order is fairly similar for in 
vivo and in vitro data, and we therefore conclude that the quali-
tative embryotoxic potential is fairly well predicted by the eSt 
for these five conazoles. However, in vivo potency of epoxico-
nazole compared to prochloraz could not be discriminated by 
the eSt.
Various in vivo data indicate that the timing of exposure dur-
ing gestation may be important for the adverse effects observed. 
Taxvig et al. (2007, 2008) found that epoxiconazole had several 
adverse embryotoxic outcomes such as increased post-implan-
tation loss and late resorptions in Wistar rats (tab. 2). De Cas-
tro and Maia (2012) investigated the effects of epoxiconazole 
in the same rat strain and did not find developmental toxicity 
parameters to be altered even at a dose of 150 mg/kg bw/day. 
Differences in the dosing period between the studies (i.e., GD1-
6 or GD6-15 in the de Castro study versus from GD7-21 and 
throughout lactation in the taxvig study) are likely to explain 
the observed difference. this would imply that dosing during 
the final week of pregnancy or during lactation may be the criti-
cal period of concern of exposure to epoxiconazole (de Castro 
and Maia, 2012). Choosing the relevant dosing period is critical 
regarding developmental toxicity, not only for conazoles, but 
for all chemicals.
Other in vitro models have studied the embryotoxic effects 
of the conazole compounds. Among these are the post-im-
plantation whole embryo culture (WeC) teratogenicity assay 
that investigates the growth in vitro of rodent embryos dur-
ing some days in the period of organogenesis (Giavini and 
Menegola, 2010). Several WeC studies using rat or mouse 
embryos showed that conazoles were able to produce specific 
malformations in embryos. For instance, tebuconazole induced 
branchial arches malformations at exposure levels of 62.5-250 
µM and in a concentration-related manner in the rat WeC sys-
tem (Di Renzo et al., 2011). Additionally, severe abnormalities 
including abnormally shaped otic vesicle and head length were 
concentration-related and observed in rat embryos exposed to 
10-100 µM ketoconazole (Menegola et al., 2006; Bechter and 
Schmid, 1987; Kucera et al., 1993). Also, propiconazole inter-
fered with embryonic development of the crustacean Daphnia 
magna (Kast-Hutcheson et al., 2001). In a study by de Jong et 
al. (2011) comparing EST, rat WEC, and the Zebrafish Em-
bryotoxicity Test (ZET), six related triazole compounds inhib-
ited cardiomyocyte differentiation concentration-dependently 
in eSt. these data support the hypothesis regarding the sug-
gested embryotoxicity potential of the conazoles and further 
underline that this may be a general effect caused by this class 
of chemicals. the study also concluded that Zet gave the best 
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pups observed after exposure to several of the conazoles (Tab. 
4). In addition, the increased progesterone levels in dams could 
explain the prolonged pregnancy period (tab. 2) (Vinggaard et 
al., 2005).
Data on endpoints from in vivo developmental toxicity 
endpoints affected by the conazole fungicides were collected 
and presented in Table 4. The parameters included common 
endpoints such as male reproductive organ weight, anogenital 
indicate an inhibition of enzymes involved in the conversion of 
progesterone to testosterone and might be due, at least partly, to 
inhibition of CYP17 (Laier et al., 2006), an effect that has been 
confirmed in vitro in H295R cells and in testicular microsomes 
(Blystone et al., 2007; Ayub and levell, 1987; Ohlsson et al., 
2010). the increased progesterone levels in the dams are sug-
gested to cause virilization of the female offspring (Taxvig et 
al., 2007), which would explain the increased AGD in females 
Tab. 3: Overview of data for five conazole fungicides obtained from in vitro assays commonly used to evaluate  
endocrine disrupting properties
Range of lowest-observed-effect-concentrations (LOECs), EC50 (effect concentration eliciting 50% of maximum response),  
IC25/50 (inhibitory concentration resulting in 25% or 50% of control response, respectively), or REC20 (relative effective concentration 
eliciting 20% of positive agonist response) values in µM are shown. Numbers in parentheses are the reference  
identification numbers as listed in Supplementary materials at www.altex-edition.org. AhR = aryl hydrocarbon receptor, AR = androgen 
receptor, NI = parameter not investigated. Colors indicate the potency of each chemical in each assay. Potency in terms of exposure 
concentrations were converted into colors using an arbitrary scale selected as shown in the row marked scale.
                    In vitro endpoints for endocrine disruption
     Steroidogenesis   
Conazole  AR Antiestroge- AhR trans-
 Estradiol Testosterone Progesterone Aromatase fungicide antagonism nicity activation
 production↓ production↓ production↑ inhibition 
Epoxiconazole LOEC:1.6-2 LOEC:25 LOEC:6.3 LOEC:0.1 LOEC:3 LOEC:0.3 LOEC:1-100 
 (1,30,31) (30) (33) (30) (30) (30) (30,34,35)
 3<IC25<10 IC50:52  IC50:0.2 IC50:5.3  IC50:1.44-20 
 (32) (30)  (30) (30)  (30,34,36)
 IC50:10 
 (30)
Ketoconazole 3<IC25<10 LOEC:0.2 NI LOEC:1-5 LOEC:0.03-9.4 LOEC:1-5 LOEC:6.3 
 (32) (30)  (30,37-40) (30,37-40,42-44) (30,37,40) (30)
  IC50:12  IC50:0.62-2.3 IC50:0.08-0.26  IC50:0.9-281 
  (30)  (30,41) (30,41,45)  (30,34,46-51)
Prochloraz LOEC:1.9-10 LOEC:1-25 LOEC:0.05-1 LOEC:0.01-5 LOEC:0.01-30 LOEC:0.01-5 LOEC:0.3-50 
 (1,13,30,52) (30,52,56) (33,57) (17,30,37-40) (17,30,37-40,59) (17,30,37,40) (30,34,38,52,61,62)
 3<IC25<10 IC50:22-29 REC20:0.71 IC50:0.02 IC50:0.005 EC50:0.21 IC50:0.047-15 
 (32) (30,56) (58) (30) (30) (41) (30,34,50,51,60-62)
 IC50:3.6-13       
 (30,53-55)
Propiconazole LOEC:12.5-25 LOEC:1 LOEC:12.5 LOEC:1-30 LOEC:10 LOEC:0.3 LOEC:1-50 
 (30,31) (30) (33) (30,63) (30,63) (30) (30,61,62)
 3<IC25<10 IC50:55  IC50:0.9 IC50:5.3  IC50:0.968-199 
 (32) (30)  (30) (30)  (30,34,51,60-62,64)
 IC50:18       
 (30)      
Tebuconazole LOEC:0.5-3.8 LOEC:1.6 LOEC:6.3 LOEC:3 LOEC:0.1 LOEC:10 LOEC:10 
 (1,30,31) (30) (33) (30) (30) (30) (30)
 1<IC25<3 IC50:49  IC50:1.2 IC50:0.5  IC50:5.8-609 
 (32) (30)  (30) (30)  (30,34,51,60)
 IC50:8.1       
 (30)      
Scale x≤0.05 0.05<x≤0.1 0.1<x≤0.5 0.5<x≤1 1<x≤5 x>5
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conazole, and tebuconazole seem to be the most potent male 
reproductive toxicants affecting either male AGD, nipple re-
tention and/or fetal testosterone. On the other hand, epoxico-
nazole and propiconazole seem to affect the female pups to a 
higher degree. Overall, prochloraz ranks the most potent en-
docrine disruptor based on interference with steroidogenesis 
in vitro (tab. 3). In agreement with this, in vivo data show that 
prochloraz appears to affect all studied endpoints adversely 
and propiconazole shows the lowest potency both in vitro and 
in vivo. Affinities and potencies for selected CYP enzymes, 
i.e., CYP17, CYP19, CYP26, and CYP51, appear to be the 
mechanism eliciting the functional and adverse effects of the 
conazole fungicides and differential CYP inhibition profiles 
may explain the observed differences in their embryotoxic 
and developmental toxic profile.
distance (AGD), number of male areolas, and hormone levels 
in pups. there is, however, a lack of available data on ke-
toconazole in that respect. The in vivo findings suggest that 
prochloraz, ketoconazole, and tebuconazole mainly affect 
male reproductive health endpoints – effects that conceivably 
are mediated by reduced testosterone during gestation. the 
findings on epoxiconazole and propiconazole indicate that 
they mainly affect female reproductive health, e.g., disruption 
of estrous cycle (Rockett et al., 2006) and time until vaginal 
opening (de Castro and Maia, 2012) defining the onset of pu-
berty in female rats (Firlit and Schwartz, 1977). These two 
conazoles also show a weak estrogenic response in vitro in 
the MCF-7 cell proliferation assay (data not included in tab. 
3) (Kjaerstad et al., 2007), a mode of action that might con-
tribute to the effect on female reproduction. Prochloraz, keto-
Tab. 4: Overview of data for five conazole compounds causing significant in vivo developmental toxicity
Ranges of doses in mg/kg bw/day are shown; ↑↓ indicate an increase or decrease in the investigated parameter, respectively.  
Numbers in parentheses are the reference identification numbers as listed in Supplementary materials at  
www.altex-edition.org. Italic numbers refer to the tested dose range in mg/kg bw/day in all included studies. AGD = anogenital distance, 
NI = parameter not investigated, NS =  effect not significant. Lowest-observed-adverse-effect-level (LOAEL) values (in mg/kg bw/day) 
were converted into colors using an arbitrary scale selected as shown in the row marked scale. Non-significant effects were assigned  
the highest LOAEL value in the scale. Diagonal hatching was assigned to results that indicate an increase in feminization of female 
offspring or a masculinization of male offspring, respectively. 
    In vivo developmental toxicity endpoints
               AGD   Hormone levels in ♂ pups
Conazole Repro-   No.  Testos- Proges- 17α- Andro- Other 
fungicide ductive ♂ ♀ areolas ♂ terone terone hydroxy- stene- 
(mg/kg bw/day) organ      proges- dione 
 weight ♂      terone 
Epoxiconazole ↑15 ↑3.75,15 ↑3.75-50 NS NS NS NS NI Time to vaginal 
≈ 1-15  (65) (1,2) (1,2) (2) (7) (7) (2)  opening ↓150
         Time to testes  
         descent ↑150 
         (66)
Ketoconazole NI ↓50 ↓50 NI ↓50 NI NI NI - 
50   (7) (7)  (7) 
Prochloraz ↓30-250 ↓50-150 ↑8.75-150 ↑30-250 ↓30-250 ↓50 ↑7.8-125 ↓31.3,125 - 
5-500  (12,13,16, (13,17) (1,13,17) (1,12,13,17) (12,16,17,67) ↑7.8-250 (16) (16) 
 17,65)     (12,16,17,67)  
Propiconazole ↑≈36-414 ↑≈145-174 NS NI ↑≈36-414 NI NI NI Female fertility 
≈ 7.6-414  (23) (23) (23)  (23)    ↓≈36-414 
         (22,23)
Tebuconazole ↓60-988 ↑100 ↑12.5-100 ↑50,100 ↓100 ↑50 ↑50,100 NI Fertility 
12.5-988  (24,29,68) (2) (1,2) (1,2) (2) (2,7) (2)  ↓300 
         (29)
Scale LOAEL≤10 10<LOAEL≤30 30<LOAEL≤50 50<LOAEL≤70 70<LOAEL≤100 LOAEL>100
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4  Conclusion
the overall objective of this study was to retrospectively evalu-
ate the predictability of a battery of in vitro methods for evaluat-
ing embryotoxicity and developmental toxicity for five cona-
zole fungicides. All five conazoles were classified as “weakly 
embryotoxic” in the eSt, and ranking of their potencies based 
on ID50 values for inhibition of beating occurrence in cardiomy-
ocytes showed fairly good correlation with in vivo embryotoxic 
endpoints. However, in animal studies epoxiconazole appeared 
to have a stronger embryotoxic potential compared to prochlo-
raz, a difference that was not predicted by EST. The critical 
mechanism for both imidazoles and triazoles on endpoints of 
developmental toxicity seems to be inhibition of enzymes in-
volved in sex hormone biosynthesis. Based on data from the 
H295R steroidogenesis assay prochloraz was found to be the 
most potent endocrine disruptor in vitro, an effect that resulted 
in a broader variety of adverse in vivo developmental effects.
The disparity in influence on adverse in vivo developmental 
and embryotoxic effects observed between the conazole fungi-
cides is likely a result of differences in affinities and potencies 
for the various CYP enzymes (i.e., CYP17, CYP19, and CYP26) 
believed to be affected during gestation and/or lactation. In this 
paper we showed that a battery of in vitro test methods, includ-
ing the H295R steroidogenesis assay and the eSt assay can be 
used as an effective initial approach for ranking of conazoles in 
relation to adverse health effects such as developmental toxic-
ity and embryotoxicity. Data obtained from the AR, eR, and 
AhR reporter gene assays and the CYP19 assays contributed 
with mechanistic information but were not determining factors 
for the in vivo predictability for this class of compounds. thus, 
a holistic evaluation of a battery of relevant assays may give 
important hints on the toxicological outcome in animal studies 
and hints on the critical mode and mechanisms of action of the 
chemicals, thereby saving resources and animals in the design 
of potential future studies.
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